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358a Tuesday, February 5, 2013characterized by chronic progressive weakness whose affected members harbor
a novel Cav1.1 R1242G mutation affecting the third arginine in S4 of domain
IV. Whole-cell patch clamp recordings of the R1242G mutant showed a strong
hyperpolarized shift of steady-state inactivation in GLT mouse myotube ex-
pression system. The facilitated inactivation resulting in the reduction of chan-
nel availability may account for the chronic progressive weakness of the
patients. In addition, we found an outward gating pore current through the mu-
tant voltage sensor of R1242G which might induce a reduction in the amplitude
and duration of the action potential and cause the failure of muscle fiber
excitability.
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Blocking voltage-dependent CaV1/CaV2 channels is a prevailing or potential
therapy for myriad diseases ranging from hypertension to Parkinson’s disease,
but a major limitation is lack of selective small-molecule inhibitors for distinct
CaV1/CaV2 channels. Here, we report a general bio-inspired approach towards
developing novel CaV1/CaV2 channel blockers (CCBs). We discovered that
different proteins (CaVb, 14-3-3, camodulin, and calmodulin-dependent protein
kinase II) that bind to spatially distinct re-
gions of pore-forming a1-subunit intracel-
lular loops can be converted into CCBs,
with tuneable selectivity and potency, sim-
ply by their anchoring to the plasma mem-
brane. The principle is extendable to small
molecules— engineering FKBP into spe-
cific sites within CaV1.2 a1C intracellular
loops permitted heterodimerization-
initiated channel inhibition with rapamycin
(Fig). The results reveal a universal method
for developing novel genetically-encoded
and small-molecule CCBs.
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L-type Ca2þ channels convey vital Ca2þ inflow, which is critically down-
regulated by intracellular Ca2þ. This Ca2þ-dependent inactivation (CDI) is
only present in channels initially preassociated with Ca2þ-free calmodulin
(apoCaM), where subsequent Ca2þ binding to this ‘resident’ calmodulin
(CaM) inactivates channels (Nature463:968). Channels lacking preassociated
apoCaM fail to undergo CDI. Canonical L-type channels bind apoCaM so av-
idly that nearly all channels are ‘charged’ with apoCaM. However, natural var-
iants feature potentially lower apoCaM affinity, so fluctuations in ambient
apoCaM may tune overall CDI. Here, we demonstrate that channel preassoci-
ation with apoCaM does more than simply enable CDI, and strikingly enhances
open probability (PO). For example, in single-channel Ba
2þ currents (to avoid
CDI), taken from a variant with low apoCaM affinity, openings are sparse under
baseline apoCaM (a, left), but prolific upon apoCaM overexpression (a, right).
Corresponding PO-V relations confirm this effect of apoCaM (b). Importantly,
the baseline PO of differing channel vari-
ants increases with channel/apoCaM affin-
ity via a Langmuir function (c). Thus, PO
variability reflects differences in apoCaM
preassociation, not contrasts in channel
composition per se. These results suggest
that ambient apoCaM levels can tune both
CDI and PO of channels.
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United Kingdom, 3NASA Ames Research Center, Moffett Field, CA, USA.Brownian dynamics were simulated for the simple model of calcium channels
introduced by Nonner and Eisenberg, computing electric forces from all
charges. Permanent charge (of acidic side chains) was varied. Substantial con-
duction was found only at certain discrete
values of permanent charge. Different con-
duction states had different selectivity, one
resembling L-type CaV1 and the other RyR
channels. We speculate that thermally acti-
vated switching between conductance
values could produce some types of spon-
taneous gating. Below is calcium current
J as a function of permanent charge Qf
and calcium concentration. Details at
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Voltage-gated ion channels exhibit complex forms of gating, which can be tar-
geted in pharmacological therapies for disease. Here, we report that the pro-
oxidant, tert-butyl dihydroquinone (BHQ), modulates Cav2.1 Ca2þ channels
in ways that oppose defects in channel gating and synaptic transmission result-
ing from a familial hemiplegic migraine mutation (S218L). BHQ inhibits
voltage-dependent activation and unmasks slow deactivation that is enhanced
by Ca2þ and more prevalent in S218Lmutant than in wild-type channels. These
actions of BHQ help reverse the gain-of-function and reduced Ca2þ-dependent
facilitation of Cav2.1 channels with the S218L mutation. Transgenic expres-
sion of the mutant channels at the Drosophila neuromuscular junction causes
abnormally elevated evoked postsynaptic potentials and impaired synaptic
plasticity, which are largely restored to the wild-type phenotypes by BHQ.
Our results reveal a new mechanism by which Cav2.1 gating modifiers can cor-
rect defects associated with disease-causing mutations in Cav2.1.
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Voltage-gated calcium channel (CaV) activity is regulated by calcium sensors
including calmodulin (CaM) and calcium-binding protein 1 (CaBP1). CaBP1
inhibits CaM-mediated calcium-dependent inactivation (CDI). We investigated
the origins of functionally important differences between CaM and CaBP1 by
creating a number of CaM/CaBP1 chimeras which suggest that both calcium
sensors use their C-lobes for high affinity binding to the pore-forming CaV
alpha-subunit, while their N-terminal lobe are responsible for the stark
functional differences of the calcium sensors. CaBP1 and CaM are thought
to modulate CaV function by competing for binding to the CaV C-terminal
IQ-domain, but this assumption has never been tested directly. By determining
CaV1.2 CDI in Xenopus oocytes under conditions with different ratios of CaM
and CaBP1, we demonstrate direct competition between both calcium sensors
for their CaV1.2 binding site. In order to extend our analysis of CaBP1/CaM
competition we used isothermal titration calorimetry to determine the affinity
of both CaM and CaBP1 in both calcium-bound and apo-states for the IQ
domain, suggesting that competition occurs mainly in the apo-state. Overall,
our data provide a framework for understanding how CaBP1 and CaM differ-
entially regulate CDI on CaV1.2.
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Voltage-gated Ca2þ channels (CaV) consist of four tandem transmembrane re-
peats (I-IV), each including two pore-forming helices and four segments that
make up a voltage-sensing domain (VSD). To understand voltage-dependent
Tuesday, February 5, 2013 359agating in human CaV1.2 channels, we have optically tracked the activation of
the S4 helices of repeats I, III and IV by site-directed fluorescent labeling of
introduced Cysteines with thiol-reactive probes. The channels were co-
expressed with their modulatory subunits b3 and a2d in Xenopus oocytes. Ionic
current and fluorescence emission were simultaneously recorded using the cut-
open oocyte voltage clamp fluorometry technique. Prior voltage-clamp, oo-
cytes were injected with 100 nl 80 mM BAPTA.4K, to prevent the activation
of endogenous Ca2þ-gated Cl channels. The extracellular solution contained
2 mMBa2þ or 10 mMCa2þ as charge carrier. Gating currents were recorded by
replacing Ca2þ or Ba2þ with Co2þ. 0.1 mM ouabain was added to abolish Naþ/
Kþ ATPase non-linear charge movement. Voltage-dependent fluorescence
changes (DF) were reported by fluorophores attached to substituted Cysteines
at the extracelular end of the S4 segment in repeats I, III and IV, tracking local,
voltage-dependent conformational rearrangements. The voltage dependence of
observed fluorescence deflections preceded ionic activation, reporting repeat-
specific VSD transitions taking place during shut states of the channel. Pro-
longed sojourns at depolarized potentials (þ50 mV) shifted the voltage-
dependence of reported DF to more hyperpolarized potentials by >50mV, re-
capitulating previously-characterized gating current properties. In summary,
we report the first optical characterization of VSD conformational changes in
a human voltage-gated Ca2þ channel, revealing repeat-specific voltage- and
time-dependent properties.
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Ca2þ influx through L-type (CaV1.2) channels in heart regulates excitation-
contraction (EC) coupling, action potential duration, and gene expression.
This versatility of L-type channels in heart is hypothesized to be mediated
in part by differential sub-cellular compartmentalization and hormonal modu-
lation of distinct CaV1.2 channel pools in cardiac myocytes. Such prevailing
hypotheses are best tested directly in cardiac myocytes, since their unique
cyto-architecture and signaling environment cannot be replicated in heterolo-
gous cells. There are two major hurdles: first, the large size of pore-forming
a1C subunits exceeds the packaging capacity of viral vectors, necessary to
express exogenous CaV1.2 channels in adult cardiac myocytes; second,
endogenous channels are a source of confounding contaminating signals. To
overcome these limitations, we focused on functionally reconstituting two
separately expressed moieties of the channel using a novel split-intein-
mediated protein splicing approach. In HEK 293 cells, split-intein fragments
were trans spliced to generate full-length a1C as determined by Western
blot. When co-expressed with auxiliary b subunits, trans-spliced a1C trafficked
normally to the cell surface and yielded robust whole-cell currents (ICa). The
split-intein fragments were readily incorporated into adenoviral vectors which
when used to infect adult myocytes yielded trans-spliced a1C that was detected
at the cell surface. To isolate exogenous ICa, we introduced mutations that
reduced dihydropyridine sensitivity of trans-spliced a1C (a1CDHP-). In the pres-
ence of 10 mM nifedipine, myocytes expressing trans-spliced a1CDHP- yielded
significantly larger currents than controls expressing trans-spliced a1C. The
results demonstrate a novel approach to robustly engineer the pore-forming
a1C subunit composition of CaV1.2 channels in cardiac myocytes, removing
a longstanding technical obstacle to L-type channel structure-function studies
in heart.Platform: Protein Assemblies & Aggregates
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Islet amyloid polypeptide (IAPP, Amylin) is responsible for amyloid formation
in type 2 diabetes and in islet cell transplants. The mechanism of IAPP toxicity
is poorly understood. Here we identify and characterize the toxic species
produced during amyloid formation by human IAPP. using a combination of
time-dependent biophysical and biological assays, we show that the transiently
populated pre-fibrillar intermediates formed in the early phase of amyloid
formation are toxic and they are loosely packed with very modest amountsof secondary structure. The only known natural mutation found in mature
human IAPP is a Ser20-to-Gly mis-sense mutation, which appears to be asso-
ciated with an increased risk of early-onset type 2 diabetes. We demonstrate
that the mutant accelerates amyloid formation under physiologically relevant
conditions. We rationally design another variant at residue 20, S20K-IAPP,
which is much slower to aggregate with an 18-fold longer lag phase and inhibits
wild type amyloid formation. The pronounced effects of the Ser20 mutants
highlight the sensitivity of amyloid formation to the identity of position 20.
By comparing the kinetics and toxicity profiles of the two Ser20 mutants to
wild type IAPP, we demonstrate that changes in the length of the lag phase
directly correlate with changes in the onset and the duration of toxicity. Our
findings provide direct evidence that the toxic species are transient intermedi-
ates and have implications for the treatment of type 2 diabetes and other
amyloid related diseases.
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Accumulating evidences suggest that many neurodegenerative diseases includ-
ing Alzheimer’s disease (AD) are linked with cytotoxic diffusible aggregates of
amyloid proteins, which are metastable intermediate species in protein misfold-
ing. Despite increasing importance of the amyloid intermediates, very little has
been known on their structures, relationship with amyloid fibril, and pathogenic
functions. This work presents a site-specific structural study on an intermediate
called amylo-spheroid (ASPD)(1) for 42-residue Alzheimer’s b (Ab(1-42)) by
solid-state NMR (SSNMR), which offers means to characterize metastable
amyloid intermediates.(2) As the ASPD level in a brain correlates with the se-
verity of AD, ASPD is likely an intermediate pathogenically relevant to AD.(1)
We demonstrate that detailed structural examination by 13C SSNMR is possible
on synthetic ASPD that well mimics native ASPD isolated from a brain extract
from an AD patient. Electron micrograph and immunological analyses using an
ASPD-specific ‘‘conformational’’ antibody confirm that morphologies and con-
formations of the synthetic ASPD used for the present NMR analysis are sim-
ilar to native ASPD. 13C SSNMR chemical-shift analysis over 20 residues
demonstrated that ASPD is made of a homogeneous conformer that is largely
composed of b-sheet structure. An inter-strand 13CO-13CO distance measure-
ment suggests that the ASPD involves a parallel b-sheet arrangement despite
the fact that ASPD does not bind to fibril-specific dyes such as thioflavin-T.
The structural features of ASPD will be compared with those of amyloid fibril
for Ab(1-42), which were elucidated by SSNMR analysis. The approach pre-
sented here is likely to open an avenue to examine structural details of various
amyloid intermediate species pathologically relevant to AD or other amyloid
diseases, for which structures have been poorly characterized.
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The proteolytic cleavage of the transmembrane amyloid precursor protein (APP)
produces amyloid-b peptides (Ab) that vary from 38 to 43 amino acids in length.
Two of these peptides, Ab1-40 and Ab1-42, are the major components of the ex-
tracellular amyloid plaques characteristic of Alzheimer’s disease (AD). Within
these plaques, the Ab is found aggregated into long polymeric assemblies rich in
b-sheet structure that are known as amyloid fibrils. Although the correlation
between plaque load and disease severity is poor there is strong evidence that
small soluble oligomers of Ab formed during the early stages of the aggregation
process are the agents of AD-associated neurotoxicity (1). Single molecule
fluorescence techniques have the potential to resolve the size and structural
heterogeneity of these oligomers, which are often difficult to discern by ensem-
ble methods. Most importantly, they allow the characterisation of small oligo-
meric species at the nucleation stage of the aggregation as the structures of
amyloid seeds remain ambiguous (2). Equimolar mixtures of Ab1-42 singly
labelled with either HiLyteFluor-488 or HiLyteFluor-647 were studied using
